PENDARVIS DAVID 4
4 · RESMED INC · Filed Apr 5, 2023
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Sale
ResMed Common Stock
2023-04-03$218.23/sh−1,500$327,345→ 92,672 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022.